Vincent Medical Holdings Limited (1612.HK)

HKD 0.38

(0.0%)

EBITDA Summary of Vincent Medical Holdings Limited

  • Vincent Medical Holdings Limited's latest annual EBITDA in 2023 was 104.43 Million HKD , up 208.17% from previous year.
  • Vincent Medical Holdings Limited's latest quarterly EBITDA in 2024 Q2 was 42.9 Million HKD , down 0.0% from previous quarter.
  • Vincent Medical Holdings Limited reported an annual EBITDA of 28.28 Million HKD in 2022, down -72.01% from previous year.
  • Vincent Medical Holdings Limited reported an annual EBITDA of 119.52 Million HKD in 2021, down -64.23% from previous year.
  • Vincent Medical Holdings Limited reported a quarterly EBITDA of N/A for 2023 FY, up 208.17% from previous quarter.
  • Vincent Medical Holdings Limited reported a quarterly EBITDA of 49.32 Million HKD for 2023 Q2, down 0.0% from previous quarter.

Annual EBITDA Chart of Vincent Medical Holdings Limited (2023 - 2013)

Historical Annual EBITDA of Vincent Medical Holdings Limited (2023 - 2013)

Year EBITDA EBITDA Growth
2023 104.43 Million HKD 208.17%
2022 28.28 Million HKD -72.01%
2021 119.52 Million HKD -64.23%
2020 334.17 Million HKD 491.33%
2019 56.51 Million HKD -8.58%
2018 58.12 Million HKD 10.96%
2017 55.7 Million HKD -28.15%
2016 77.53 Million HKD -9.86%
2015 86.01 Million HKD 29.6%
2014 65.81 Million HKD 43.1%
2013 46.37 Million HKD 0.0%

Peer EBITDA Comparison of Vincent Medical Holdings Limited

Name EBITDA EBITDA Difference